FDA Adverse Event Malfunction Summary report: N

CE INFUSOR, LV 5 ML/H,12 PACK

MDR report key: 1973252 · Received January 28, 2011

Report

Report Number
6000001-2011-00505
Event Type
Malfunction
Date Received
January 28, 2011
Date of Event
February 3, 2010
Report Date
January 4, 2011
Product Code
MEB
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
CH
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). ADDITIONAL NARRATIVE: THE DEVICE HAS BEEN RECEIVED BY BAXTER FOR EVALUATION; HOWEVER, THE EVALUATION HAS NOT YET BEEN COMPLETED. A FOLLOW-UP REPORT WILL BE SUBMITTED UPON COMPLETION OF THE EVALUATION AND/OR SHOULD ANY ADDITIONAL INFORMATION BECOME AVAILABLE. THIS DEVICE IS MANUFACTURED FOR DISTRIBUTION OUTSIDE OF THE UNITED STATES (US); THEREFORE, IT DOES NOT CONTAIN A US 510K NUMBER. HOWEVER, THIS MDR IS BEING SUBMITTED BECAUSE IT IS THE SAME AS OR SIMILAR TO A PRODUCT DISTRIBUTED WITHIN THE US.

Additional Manufacturer Narrative · 1

(B)(4). DEVICE EVALUATION: ONE SAMPLE WAS RECEIVED BY BAXTER FOR EVALUATION. THE REPORTED CONDITION OF "BACKFLOW" WAS CONFIRMED DUE TO A TINY GLASS FRAGMENT FOUND UNDERNEATH THE CHECK-BAND. NO OTHER CAUSE OF BACK-FLOW WAS FOUND DURING THE EXAMINATION. THE GLASS FRAGMENT WAS INTRODUCED INTO THE FLUID PATHWAY DURING FILLING BY THE CUSTOMER WITHOUT THE USE OF A FILTER. A BATCH REVIEW WAS CONDUCTED AND NO ISSUES WERE FOUND RELATED TO THE REPORTED CONDITION DURING THE MANUFACTURE OF THE LOT. BAXTER WILL CONTINUE TO MONITOR SIMILAR REPORTS TO DETERMINE IF FURTHER ACTIONS ARE REQUIRED.

Description of Event or Problem · 1

IT WAS REPORTED TO BAXTER (B)(4) THAT ONE (1) CE INFUSOR WAS OBSERVED LEAKING AT THE FILL PORT DURING FILLING. THERE WAS NO PATIENT INVOLVEMENT. NO ADDITIONAL INFORMATION IS AVAILABLE. THIS IS REPORT 2 OF 2 WITH THE SAME REPORTED PROBLEM FROM THIS FACILITY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 CE INFUSOR, LV 5 ML/H,12 PACK PUMP, INFUSION, ELASTOMERIC MEB 09C010

Patients

Seq Age Sex Outcome Treatment
1